Cost-effectiveness analysis: Some clarifications

Radiology

Volumn 249, Issue 3, 2008, Pages 753-755

  Hunink, M G Myriam ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENTEEISM; AGING; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC IMAGING; HEALTH CARE COST; LIFE EXPECTANCY; PRIORITY JOURNAL; PRODUCTIVITY; QUALITY OF LIFE; REVIEW; UNITED STATES; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; ECONOMICS; NOTE; RADIOLOGY; UNITED KINGDOM;

COST-BENEFIT ANALYSIS; DIAGNOSTIC IMAGING; GREAT BRITAIN; RADIOLOGY; UNITED STATES;

EID: 58149177690     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2493081479     Document Type: Review

References (12)

1. American College of Physicians. Information on cost-effectiveness: an essential product of a national comparative effectiveness program. Ann Intern Med 2008;148(12):956- 961.
2. Claxton K, Sculpher M, Drummond M. A rational framework for decision making by the National Institute for Clinical Excellence (NICE). Lancet 2002;360(9334):711-715.
3. America's imaging problem. National Imaging Associates Web site. http://www.radmd.om/imaging-problem/imaging-problem.htm. AccessedAugust18, 2008.
4. Otero HJ, Rybicki FJ, Greenberg D, Neumann PJ. Twenty years of cost-effectiveness analysis in medical imaging: are we improving? Radiology 2008;249(3): 917-925.
5. Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-effectiveness in health and medicine. New York, NY: Oxford University Press, 1996.
6. National Institute For Clinical Excellence (NICE). Guide to the methods oftechnology appraisal. Oxford, England: Radcliffe Medical Press, 2004.
7. Oostenbrink JB, Koopmanschap MA, Rutten FF. Standardisation ofcosts: the Dutch manual for costing in economic evaluations. Pharmacoeconomics 2002;20(7):443-454.
8. Hunink M, Glasziou PP, Siegel JE, et al. Decision making in health and medicine: integrating evidence and values. Cambridge, England: Cambridge University Press, 2001.
9. Brouwer WB, Niessen LW, Postma MJ, Rutten FF. Need for differential discounting of costs and health effects in cost effectiveness analyses. BMJ 2005;331(7514):446 - 448.
10. Gravelle H, Brouwer W, Niessen L, Postma M, Rutten F. Discounting in economic evaluations: stepping forward towards optimal decision rules. Health Econ 2007;16(3):307-317.
11. Koopmanschap MA, Rutten FF, van Ineveld BM, van Roijen L. The friction cost method for measuring indirect costs of disease. J Health Econ 1995;14(2):171-189.
12. Neumann PJ, Greenberg D, Olchanski NV, Stone PW, Rosen AB. Growth and quality of the cost-utility literature, 1976-2001. Value Health 2005;8(1):3-9.